Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain
- PMID: 29477301
- DOI: 10.1016/j.neuropharm.2018.02.013
Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain
Abstract
Although chemotherapy increases the survival rate of patients with various cancers, such treatment can induce acute or long-term cognitive dysfunction a phenomenon known as post-chemotherapy cognitive impairment (PCCI) or "chemobrain." Exercise is known to positively affect brain function. Thus, the present study aimed to determine whether symptoms of chemobrain and disruptions in the neuroplasticity and functioning of hippocampal mitochondria can be prevented or relieved by exercise. Wistar rats were separated into the following groups: control, control plus exercise, chemobrain, and chemobrain plus exercise. For chemobrain induction, 2 mg/kg of doxorubicin (DOX) a widely utilized chemotherapeutic agent among patients with breast cancer was dissolved in saline and directly injected to the abdomen once every 4 weeks. The exercise groups were subjected to low-intensity treadmill, 6 days per week for 4 weeks. The Morris water maze and step-down avoidance tests were conducted to evaluate cognitive function, while neuroplasticity and mitochondrial function were assessed in the hippocampus and dentate gyrus. Decreased cognitive function were observed in the chemobrain group, along with decreases in levels of neurogenesis, brain derived neurotrophic factor (BDNF), tropomyosin-related kinase B (TrkB), Ca2+ retention in hippocampus. Rats of the chemobrain group also exhibited an increase in apoptosis, H2O2 emission and permeability transition pore by hippocampal mitochondria. However, exercise attenuated impairments in cognitive function, neuroplasticity, and mitochondrial function induced by DOX treatment. Therefore, the findings of the present study indicate that low-intensity exercise may assist in preventing cognitive dysfunction during or after chemotherapy in patients with various cancers, including breast cancer.
Keywords: Chemobrain; Cognitive function; Exercise; Hippocampus; Mitochondria; Neuroplasticity.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
Combined exercise ameliorates ovariectomy-induced cognitive impairment by enhancing cell proliferation and suppressing apoptosis.Menopause. 2016 Jan;23(1):18-26. doi: 10.1097/GME.0000000000000486. Menopause. 2016. PMID: 26057823
-
Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation.Neuropharmacology. 2020 Dec 15;181:108334. doi: 10.1016/j.neuropharm.2020.108334. Epub 2020 Oct 1. Neuropharmacology. 2020. PMID: 33011199
-
Polydatin ameliorates chemotherapy-induced cognitive impairment (chemobrain) by inhibiting oxidative stress, inflammatory response, and apoptosis in rats.Biosci Biotechnol Biochem. 2020 Jun;84(6):1201-1210. doi: 10.1080/09168451.2020.1722057. Epub 2020 Jan 28. Biosci Biotechnol Biochem. 2020. PMID: 31992173
-
Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain.Cancer Chemother Pharmacol. 2019 Jul;84(1):1-14. doi: 10.1007/s00280-019-03827-0. Epub 2019 Apr 6. Cancer Chemother Pharmacol. 2019. PMID: 30955080 Review.
-
Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.Exp Neurol. 2020 Feb;324:113118. doi: 10.1016/j.expneurol.2019.113118. Epub 2019 Nov 19. Exp Neurol. 2020. PMID: 31756316 Review.
Cited by
-
The Promise of Nutrient-Derived Bioactive Compounds and Dietary Components to Ameliorate Symptoms of Chemotherapy-Related Cognitive Impairment in Breast Cancer Survivors.Curr Treat Options Oncol. 2021 Jun 10;22(8):67. doi: 10.1007/s11864-021-00865-w. Curr Treat Options Oncol. 2021. PMID: 34110516 Review.
-
Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis.Pharmaceuticals (Basel). 2022 Jul 24;15(8):918. doi: 10.3390/ph15080918. Pharmaceuticals (Basel). 2022. PMID: 35893742 Free PMC article.
-
α-Bisabolol alleviates doxorubicin-induced cognitive dysfunction in rats via enhancing the hippocampal BDNF/TrKB signaling and inhibiting neuroinflammation.Front Pharmacol. 2025 Mar 7;16:1549009. doi: 10.3389/fphar.2025.1549009. eCollection 2025. Front Pharmacol. 2025. PMID: 40124785 Free PMC article.
-
Chemotherapy-related cognitive impairment and kidney dysfunction.Nephrol Dial Transplant. 2025 Mar 13;40(Supplement_2):ii54-ii63. doi: 10.1093/ndt/gfae249. Nephrol Dial Transplant. 2025. PMID: 40080088 Free PMC article. Review.
-
Wnt3a/GSK3β/β-catenin Signalling Modulates Doxorubicin-associated Memory Deficits in Breast Cancer.Mol Neurobiol. 2024 Aug;61(8):5441-5458. doi: 10.1007/s12035-023-03910-x. Epub 2024 Jan 10. Mol Neurobiol. 2024. PMID: 38198045
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous